Cynthia Obodozie

Cynthia Obodozie currently serves as Vice President Operations Freiburg at Reaction Biology Europe GmbH since January 2023. Previously, Cynthia held the roles of Head of In Vivo Pharmacology and Head of Animal Facility at Reaction Biology Europe GmbH from January 2020 to December 2022. Prior experience includes positions at ProQinase GmbH as Group Leader In Vivo Testing and Head of Animal Facility from July 2014 to December 2019, and Group Leader in vivo Testing from July 2011 to June 2014, as well as Senior Scientist in vivo Testing from September 2008 to June 2011. Cynthia’s career began at KTB Tumorforschungs GmbH as a Postdoctoral Fellow in Vascular Biology and Angiogenesis from 2001 to 2004, and at Bayer HealthCare (formerly Schering AG) as a Senior Scientist from 1999 to 2001. Cynthia Obodozie obtained a Veterinary degree from Freie Universität Berlin between 1992 and 1999, focusing on research in in vivo Oncology, particularly in endometrial carcinoma and antiestrogens.